We are live on ! Find out more
BSX icon

Boston Scientific

556 hedge funds and large institutions have $27.2B invested in Boston Scientific in 2016 Q4 according to their latest regulatory filings, with 75 funds opening new positions, 184 increasing their positions, 223 reducing their positions, and 75 closing their positions.

New
Increased
Maintained
Reduced
Closed

36% more call options, than puts

Call options by funds: $78.3M | Put options by funds: $57.4M

0.49% more ownership

Funds ownership: 91.82%92.31% (+0.49%)

0% more first-time investments, than exits

New positions opened: 75 | Existing positions closed: 75

2% less funds holding

Funds holding: 565556 (-9)

7% less capital invested

Capital invested by funds: $29.4B → $27.2B (-$2.18B)

17% less repeat investments, than reductions

Existing positions increased: 184 | Existing positions reduced: 223

44% less funds holding in top 10

Funds holding in top 10: 169 (-7)

Holders
556
Holders Change
-9
Holders Change %
-1.59%
% of All Funds
13.9%
Holding in Top 10
9
Holding in Top 10 Change
-7
Holding in Top 10 Change %
-43.75%
% of All Funds
0.23%
New
75
Increased
184
Reduced
223
Closed
75
Calls
$78.3M
Puts
$57.4M
Net Calls
+$20.9M
Net Calls Change
-$14.7M
Name Holding Trade Value Shares
Change
Change in
Stake
CG
351
Cutler Group
California
$821K -$13.1K -600 -2%
AssetMark Inc
352
AssetMark Inc
California
$787K +$794K +36,381 New
LIA
353
LS Investment Advisors
Michigan
$737K +$27.2K +1,245 +4%
CI
354
Conning Inc
Connecticut
$732K +$9.16K +420 +1%
FNT
355
First Nebraska Trust
Nebraska
$719K -$3.97K -182 -0.5%
CC
356
ClearArc Capital
Ohio
$715K -$5.7K -261 -0.8%
MSV
357
MN Services Vermogensbeheer
Netherlands
$713K
DADC
358
D.A. Davidson & Co
Montana
$705K +$11.2K +513 +2%
RHBC
359
R.H. Bluestein & Co
Michigan
$704K -$188K -8,615 -21%
AIP
360
Ameritas Investment Partners
Nebraska
$704K
CCM
361
Catawba Capital Management
Virginia
$692K +$80.5K +3,690 +13%
NA
362
Nottingham Advisors
New York
$688K
SFI
363
SPC Financial Inc
Maryland
$687K +$214K +9,798 +45%
TRCT
364
Tower Research Capital (TRC)
New York
$676K +$590K +27,032 +637%
CA
365
Cornerstone Advisors
North Carolina
$664K +$473K +21,700 +241%
Bank of Nova Scotia
366
Bank of Nova Scotia
Ontario, Canada
$658K +$61.8K +2,832 +10%
EOJOAM
367
E. Ohman J:or Asset Management
Sweden
$655K
V
368
Veritable
Delaware
$651K -$118K -5,413 -15%
Verition Fund Management
369
Verition Fund Management
Connecticut
$644K +$63.8K +2,922 +11%
TA
370
Tamarack Advisers
California
$635K +$48K +2,200 New
SGA
371
Strategic Global Advisors
California
$630K
NI
372
Numeric Investors
Massachusetts
$621K -$1.15M -52,800 -65%
ECM
373
Everence Capital Management
Indiana
$610K -$208K -9,526 -25%
HPCM
374
High Pointe Capital Management
Illinois
$604K
NA
375
NewEdge Advisors
Louisiana
$603K +$566K +25,954 New

BSX Hedge Fund Activity: Q4 2016 in Review

556 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q4 2016, worth a combined $27.2B — down 7.4% from $29.4B a quarter earlier.

Fund positioning in BSX was balanced in Q4 2016: 75 funds opened new positions, 75 closed out, 184 added to existing stakes and 223 trimmed.

The largest buyer was Janus Henderson Investors US, adding an estimated $137M. The largest seller was Wellington Management Group, cutting an estimated $151M.

  • 556 institutional investors held Boston Scientific (BSX) as of Q4 2016, down from 565 in Q3 2016.
  • Funds reported $27.2B of Boston Scientific stock for Q4 2016, down 7.4% quarter-over-quarter.
  • 75 funds opened new Boston Scientific positions in Q4 2016 and 75 closed out, a net change of 0 holders.
  • The largest Boston Scientific buyer in Q4 2016 was Janus Henderson Investors US, an estimated $137M added.
  • The largest Boston Scientific seller in Q4 2016 was Wellington Management Group, an estimated $151M sold.

Based on aggregated 13F filings for Q4 2016.